US FDA launches pilot for one-day inspectional assessments across facilities
Initiative aims to support risk-based oversight and expand inspection coverage across programmes
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
India’s next pharma powerhouses
India’s pharma growth is increasingly being shaped not just by companies, but by clusters. From Hyderabad Pharma City and Genome…
Holista executes binding JV for collie collagen facility
Holista Colltech is pleased to announce that it has entered into a binding Joint Venture Agreement with Swang Chai Chuan (SCC) for…
Anuh Pharma get prequalification nod from WHO for anti-malarial bulk drug
Anuh Pharma has received prequalification approval from World Health Organization (WHO) for anti-malarial active pharmaceutical…
Lupin receives US FDA approval for Glycerol Phenylbutyrate oral liquid
Global pharma major Lupin announced that it has received approval from the United States Food and Drug Administration for its…
OneSource supports second generic semaglutide approval in Canada
OneSource Specialty Pharma, a leading specialty pharmaceutical CDMO, announced that its partner Orbicular, along with its Canadian…
Indoco Remedies announces strategic transfer of its ophthalmic division to Sunways India
Indoco Remedies has announced that in the Board Meeting conducted on 30th April, it has considered and approved the transfer of…
CPHI & PMEC India 2026 expand to two venues in Delhi-NCR
As the global pharmaceutical industry steers into a phase defined by innovation, advanced manufacturing, automation, and deeper…
Sun Pharma bets on Organon for its next wind
Sun Pharma’s $12 billion acquisition of Organon will prove to be a milestone as the largest takeover by an Indian pharma company.…
Syngene strengthens leadership team with two key appointments
Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced the appointment…
IDMA appoints Dr T S Parmar as Secretary General
The Indian Drug Manufacturers’ Association (IDMA) has announced the appointment of Dr T S Parmar as its new Secretary General.…
Phytopharmaceuticals in India: A case for perpetual ‘New Drug’-style regulation over ASU-style…
Introduction
Phytopharmaceuticals in India: Bridging Tradition, Science and “New Drug”-Style Regulation
Setting the stage…
Lilly supports Haryana State-FDA action against counterfeit medicines
Company responds to regulatory action and outlines guidance on procurement and product identification
SPARC to sell Rare Paediatric Disease Priority Review Voucher for $195 million
Voucher granted for Sezaby approval to be divested under asset purchase agreement
Parexel acquires Vitrana to expand pharmacovigilance technology platform
Acquisition integrates AI-enabled PV solutions with clinical and safety services
CDSCO West Zone to conduct webinar on WHO-GMP and COPP application process via ONDLS
Refresher session scheduled on April 29 for industry members and regulators
Dr Reddy’s receives Health Canada approval for generic Semaglutide Injection
Market authorisation covers 2 mg and 4 mg pen presentations in Canada
VESCOP, ENTOD and APTI Maharashtra host Vision 360 symposium on ophthalmic innovation
Symposium focuses on translating research into clinical application in ophthalmology
AKUMS launches Aztreonam-Avibactam Injection for multidrug-resistant infections
Therapy targets gram-negative bacterial infections in critical care settings
Alvarez & Marsal India appoints Nitin Lath as MD in Corporate Finance
Appointment to focus on private equity and M&A advisory in life sciences sector